Table 2.
The cell lines used in this study were obtained from the ECACC commercial repository or generated in the laboratory as previously reported67–69.
| Cell line | Species | Tissue | Culture media | Growth | Origin |
|---|---|---|---|---|---|
| A-673 | Human | Ewing’s sarcoma | RPMI | Adherent | ATCC |
| SAOS-2 | Human | Osteosarcoma | DMEM | Adherent | ATCC |
| SW-872 | Human | Liposarcoma | DMEM | Adherent | ATCC |
| IMR-90 | Human | Fibroblast* | DMEM | Adherent | ATCC |
| WI-38 | Human | Fibroblast* | DMEM | Adherent | ATCC |
| CNIO-AA | Human | Leiomyosarcoma | F10 | Adherent | LAB |
| CNIO-AW | Human | Liposarcoma | F10 | Adherent | LAB |
| CNIO-AX | Human | Liposarcoma | F10 | Adherent | LAB |
| CNIO-AZ | Human | Fibrous sarcoma | F10 | Adherent | LAB |
| CNIO-BC | Human | MPNST | F10 | Adherent | LAB |
| CNIO-BD | Human | Ewing’s sarcoma | F10 | Adherent | LAB |
| CNIO-BG | Human | Mixoid fibrosarcoma | F10 | Adherent | LAB |
| CNIO-BO | Human | Mixoid fibrosarcoma | F10 | Adherent | LAB |
| CNIO-BP | Human | Osteosarcoma | F10 | Adherent | LAB |
| CNIO-CE | Human | Rabdomyosarcoma | F10 | Adherent | LAB |
| CNIO-DA | Human | Mixoid fibrosarcoma | F10 | Adherent | LAB |
| CNIO-DD | Human | Mixoid fibrosarcoma | F10 | Adherent | LAB |
*Primary fibroblast.